Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients (CROSBI ID 228096)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Matijašić, Mario ; Meštrović, Tomislav ; Perić, Mihaela ; Čipčić Paljetak, Hana ; Panek, Marina ; Vranešić Bender, Darija ; Ljubas Kelečić, Dina ; Krznarić, Željko ; Verbanac, Donatella Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients // International journal of molecular sciences, 17 (2016), 4; 578-600. doi: 10.3390/ijms17040578

Podaci o odgovornosti

Matijašić, Mario ; Meštrović, Tomislav ; Perić, Mihaela ; Čipčić Paljetak, Hana ; Panek, Marina ; Vranešić Bender, Darija ; Ljubas Kelečić, Dina ; Krznarić, Željko ; Verbanac, Donatella

engleski

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients

The healthy intestine represents a remarkable interface where sterile host tissues come in contact with gut microbiota, in a balanced state of homeostasis. The imbalance of gut homeostasis is associated with the onset of many severe pathological conditions, such as inflammatory bowel disease (IBD), a chronic gastrointestinal disorder increasing in incidence and severely influencing affected individuals. Despite the recent development of next generation sequencing and bioinformatics, the current scientific knowledge of specific triggers and diagnostic markers to improve interventional approaches in IBD is still scarce. In this review we present and discuss currently available and emerging therapeutic options in modulating composition and metabolic activity of gut microbiota in patients affected by IBD. Therapeutic approaches at the microbiota level, such as dietary interventions alone or with probiotics, prebiotics and synbiotics, administration of antibiotics, performing fecal microbiota transplantation (FMT) and the use of nematodes, all represent a promising opportunities towards establishing and maintaining of well-being as well as improving underlying IBD symptoms.

gut microbiota ; inflammatory bowel disease (IBD) ; dietary interventions ; probiotics ; fecal microbiota transplantation (FMT) ; nematodes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

17 (4)

2016.

578-600

objavljeno

1422-0067

10.3390/ijms17040578

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost